Vancouver, BC, January 20, 2016 – Segra Biogenesis Corp is pleased to announce the appointment of Dr. Sma Zobayed, Ph.D., a Tissue Culture Production and Research Specialist to the advisory board.
Dr. Zobayed is a leading specialist in tissue culturing with extensive international experience, holds two patents relating to tissue culturing and has published over 50 scientific papers related to his research in the field. He holds a Ph.D. in Plant Tissue Culture, from the Department of Biological Sciences, University of Hull (UK), and has won awards for his tissue culture work from the scientific community. He is a member in good standing with the International Society of Arboriculture, International Association for Plant Tissue Culture and the International Society for Horticultural Sciences.
At Segra, we believe in basing our product claims for efficacy and safety on validated scientific research, and in being transparent about the sources of the research with our customers. With the appointment of Dr. Zobayed to the advisory board, the Company will be in a better position to develop high-volume tissue culture facilities and research into novel, highly standardized and reproducible Cannabis according to Company principles. For more information on the Segra management and advisory team visit http://segra-intl.com/team/.
Segra Biogenesis Corp. is an emerging specialist Research and Development Company focused on plantbased medicines, including medicinal Cannabis. Our team is driven by its experience in research and development work in medicine, genetics, tissue culture, cultivation techniques, natural medicines, biochemistry, agriculture and information technology. Segra’s goal is to research, develop, test and produce very unique and specific cultivars from the plant kingdom that are effective for specific ailments in medical patients.
Segra Biogenesis Corp
For Information Contact: